Energy, Sexual Desire and Body PropoRtions wIth AndroGel, Testosterone 1% Gel Therapy (ESPRIT) in Hypogonadal Men.

Trial Profile

Energy, Sexual Desire and Body PropoRtions wIth AndroGel, Testosterone 1% Gel Therapy (ESPRIT) in Hypogonadal Men.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Sep 2011

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Therapeutic Use
  • Acronyms ESPRIT
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 27 Jul 2011 Additional trial locations Croatia, Kuwait, Russia, Saudi Arabia, United Arab Emirates identified as reported by ClinicalTrials.gov.
    • 17 Nov 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
    • 17 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top